Funder
Social Sciences and Humanities Research Council of Canada
Reference47 articles.
1. Advanced therapy medicinal products for rare diseases: state of play of incentives supporting development in Europe;Farkas;Front Med (Lausanne),2017
2. From sandbox to pandemic: agile reform of Canadian drug regulation;Vural;Health Policy (New York),2021
3. Enzyme replacement therapy for Anderson-Fabry disease;El Dib;Cochrane Database System Rev,2016
4. The safety of agalsidase alfa enzyme replacement therapy in Canadian patients with Fabry Disease following implementation of a bioreactor process;Khan;Drugs R D,2021
5. Who should be given priority for public funding?;Bae;Health Policy (New York),2020